flow trial semaglutide kidney outcomes hazard ratio 0.76 nejm 2024 Effects of Once-Weekly on Disease by KDIGO Risk Category in the SUSTAIN 6 Get With the FLOW! in:

This slow yet steady increase allows semaglutide to continue to work as designed while minimizing potential side effects

Diarrhea Diarrhea, another gastrointestinal side effect, is experienced by about 8% of patients taking Ozempic

Assessment Aid, Orphan Drug, Priority Review, Project Orbis New indication: in combination with lenalidomide and rituximab for the treatment of adults with relapsed or refractory follicular lymphoma (FL) Limitations of use: not indicated and not recommended for the treatment of patients with relapsed or refractory marginal zone lymphoma outside of controlled clinical trials Administered as a weight-based IV infusion based on actual body weight on days one, eight, 15 and 22 of each 28-day cycle for cycles one to three and on days one and 15 of each 28-day cycle for cycles four to 12

People who are at a higher risk of constipation on Ozempic include: Older adults Those with a history of chronic constipation People taking higher doses of Ozempic Those who have inadequate fiber intake or are dehydrated Common Symptoms of Ozempic Constipation 1